Viewing Study NCT04566458


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-28 @ 4:55 AM
Study NCT ID: NCT04566458
Status: COMPLETED
Last Update Posted: 2021-10-07
First Post: 2020-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RWD Study in HER2+ mBC Patients in Third-Line Therapy
Sponsor: Exactis Innovation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Stage IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 positive View
None Real World Data View
None Metastatic Breast cancer View
None Real World Evidence View